News

The Manila Times1d
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
Poster Title: ARV-393, a PROteolysis TArgeting Chimera (PROTAC) BCL6 Degrader, is Efficacious in Preclinical Models of ...
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven By Increasing Cancer Incidences - Financial News Media
The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates there will be over 35 million new ...
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
FN Media Group News Commentary - The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates ...
Vaccine makers steady despite RFK Jr.'s removal of CDC expert panel.
In another controversial move, Health and Human Services Secretary Robert F. Kennedy Jr. has abruptly fired all 17 members of ...
Targeted Oncology4d
Vepdegestrant Shows PFS Advantage in ESR1-Mutant ER+/HER2− Breast Cancer
Vepdegestrant shows significant progression-free survival benefits over fulvestrant in advanced breast cancer, highlighting ...
Zacks Investment Research on MSN4d
Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?
Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also underperformed the sector and the S&P 500, as seen in the chart below. The ...
BlackDoctor.org5d
New Breast Cancer Research Offers Hope for Black Women
ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone ...